DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 95 filers reported holding DYNE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,779,171 | +71.7% | 107,089 | -45.3% | 0.00% | – |
| Q2 2023 | $2,200,500 | -47.5% | 195,600 | -46.2% | 0.00% | -100.0% |
| Q1 2023 | $4,188,672 | +129.1% | 363,600 | +130.5% | 0.00% | – |
| Q4 2022 | $1,828,346 | -68.4% | 157,752 | -73.7% | 0.00% | -100.0% |
| Q1 2022 | $5,784,000 | -30.8% | 600,000 | -14.7% | 0.00% | -50.0% |
| Q4 2021 | $8,363,000 | -28.2% | 703,400 | -1.9% | 0.00% | -33.3% |
| Q3 2021 | $11,646,000 | -7.7% | 717,100 | +19.5% | 0.00% | 0.0% |
| Q2 2021 | $12,624,000 | +35.5% | 600,000 | 0.0% | 0.00% | +50.0% |
| Q1 2021 | $9,318,000 | +10.9% | 600,000 | +50.0% | 0.00% | 0.0% |
| Q4 2020 | $8,400,000 | -13.5% | 400,000 | -16.8% | 0.00% | -33.3% |
| Q3 2020 | $9,707,000 | – | 480,769 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
| Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
| GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
| Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
| Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
| COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
| RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |